A Phase 3, Double-Blind, Randomized, Active Controlled Study to Evaluate the Safety of MenAfriVac in Healthy Malians

Background. A safe, affordable, and highly immunogenic meningococcal A conjugate vaccine (PsA-TT, MenAfriVac) was developed to control epidemic group A meningitis in Africa. Documentation of the safety specifications of the PsA-TT vaccine was warranted, with sufficient exposure to detect potential r...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Clin Infect Dis
Main Authors: Tapia, Milagritos D., Sow, Samba O., Haidara, Fadima Cheick, Diallo, Fatoumata, Doumbia, Moussa, Enwere, Godwin C., Paranjape, Gandhali, Hervé, Jacques, Bouma, Enricke, Parulekar, Varsha, Martellet, Lionel, Chaumont, Julie, Plikaytis, Brian D., Tang, Yuxiao, Kulkarni, Prasad S., Hartmann, Katharina, Preziosi, Marie-Pierre
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2015
Fag:
The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group a Meningococcal Conjugate Vaccine for Africa
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4639507/
https://ncbi.nlm.nih.gov/pubmed/26553682
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ626
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker